Core 1: Animal and Cell Model Core
核心1:动物和细胞模型核心
基本信息
- 批准号:10605252
- 负责人:
- 金额:$ 28.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Animal EuthanasiaAnimal ModelAnimalsAreaBackcrossingsBiologicalBiometryBloodBreedingCaloriesCell Culture TechniquesCell modelChemopreventionCollaborationsComprehensive Cancer CenterDataData CollectionDevelopmentDietDietary ComponentDigestive System DisordersDrug or chemical Tissue DistributionEnsureEnvironmentEvaluationFatty acid glycerol estersFlow CytometryFormalinGenerationsGeneticGenetically Engineered MouseGenotypeHumanHuman ResourcesIndividualInstitutionInterventionIntervention StudiesKRASG12DLaboratoriesLaboratory ResearchLeptin deficiencyLogisticsMalignant neoplasm of pancreasMedical centerModelingMonitorMusObesityOrganoidsPancreasPancreatic AdenocarcinomaPancreatic DiseasesPancreatic Intraepithelial NeoplasiaParaffinPathologyPhasePreparationPrimary Cell CulturesProceduresProcessRandom AllocationRandomizedResearch PersonnelResource SharingResourcesSamplingSampling StudiesServicesStandardizationTissue BanksTissue HarvestingTissuesTumor PromotionWorkanimal careanimal facilityanimal imaginganimal tissuecostdesigndiet-induced obesitydietary controlexperimental groupexperimental studyinnovationmembermouse modelnovelpancreatic cancer modelprogramssquare footthree dimensional cell culturetissue processingtraining projecttumor
项目摘要
PROJECT SUMMARY
The main objective of the Animal and Cell Model (ACM) Core is to provide animal and innovative cell culture
models to the Project investigators and to coordinate and standardize the shared use of the models. Integrated
into the ACM Core is the Pathology Sub-Core, which will process animal tissues to meet the needs for the
individual projects. The impact of obesity on PDAC will be investigated in KC mice with diet-induced obesity
(DIO) or genetically-induced obesity, which will allow to distinguish direct tumor promoting effects of dietary
components from true obesity effects. For the DIO model, animals will be randomly allocated to either a control
diet or a high fat, high calorie diet (HFCD) and the effect on tumor development assessed. For the genetically-
induced obesity model, KC mice will be crossed into the leptin deficient ob/ob background (KCO). The ACM
Core will carry out in collaboration with all three projects the main interventional study, in which KC mice are
treated with statins. Tissues from this large study will be shared among and analyzed by all three projects. In
addition to the main animal study, the ACM Core will conduct Project-specific interventions and will back-cross
the KC model into additional genetic backgrounds. The main objectives of the Core are 1) to provide animal-
related services and novel cell culture models to all Projects, 2) to minimize duplication of effort and reduce costs
by coordinating experiments (shared animal and tissue use), and 3) to reduce variability introduced by different
environments and husbandry and to ensure consistency in animal handling and data collection (concentration of
resources and expertise). Services that the ACM Core provides for each Project include: obtaining and
maintaining institutional approval, designing the animal studies in terms of logistics and statistical power
calculations (together with Project PI's and Biostatistics Sub-Core), maintaining animal strains and setting up
breeding pairs, genotyping of all animals, randomization of animals to experimental groups, preparation and
administration of experimental diets or interventions, daily monitoring and animal care, euthanasia of animals,
harvest of tissues and blood at sacrifice, processing tissue, e.g. fixing in formalin and embedding in paraffin, and
sectioning (together with the Pathology Sub-Core), histopathological evaluation of tissue sections (together with
the Pathology Sub-Core), generation of primary cell cultures (PanINs and murine pancreatic cancer), generating
the murine and human pancreatic organoid cultures, storage of raw data, central banking of tissues and biological
samples, distribution of tissues to individual Projects, discussion of results with Project Leaders, and training of
Project investigators in animal procedures (if desired).
项目摘要
动物和细胞模型(ACM)核心的主要目标是提供动物和创新的细胞培养
向项目调查人员进行模型,并协调和标准化模型的共同使用。融合的
进入ACM核心的是病理亚核,该病理将处理动物组织以满足对
个别项目。肥胖对PDAC的影响将在饮食引起的肥胖症的KC小鼠中研究
(DIO)或遗传诱导的肥胖症,这将允许区分饮食的直接肿瘤作用
来自真实肥胖作用的成分。对于DIO模型,动物将被随机分配给对照
饮食或高脂肪,高热量饮食(HFCD)以及评估对肿瘤发育的影响。对于遗传
诱导的肥胖模型,KC小鼠将被跨入瘦素缺乏OB/OB背景(KCO)。 ACM
核心将与所有三个项目合作进行主要介入研究,其中KC小鼠是
用他汀类药物治疗。这项大型研究的组织将在所有三个项目中共享和分析。在
除了主要动物研究外,ACM核心将进行特定项目的干预措施,并将反向交叉
KC模型成为其他遗传背景。核心的主要目标是1)提供动物 -
所有项目的相关服务和新颖的细胞培养模型,2)最大程度地减少努力的重复并降低成本
通过协调实验(共享动物和组织使用),以及3)减少不同的变异性
环境和饲养,并确保动物处理和数据收集的一致性(集中度
资源和专业知识)。 ACM核心为每个项目提供的服务包括:获取和
维持机构批准,根据物流和统计能力设计动物研究
计算(与Project Pi和Biostatistics子核一起),保持动物菌株并设置
繁殖对,所有动物的基因分型,动物与实验组的随机化,制备和
给予实验饮食或干预措施,日常监测和动物护理,动物安乐死,
牺牲时组织和血液的收获,加工组织,例如固定福尔马林并嵌入石蜡,以及
切片(与病理亚核),组织切片的组织病理学评估(一起)
病理亚核),原代细胞培养物(Panins和Murine Pancreatic Cancer)的产生
鼠类和人类胰器官培养物,原始数据的存储,组织和生物学
样本,组织分配到各个项目,与项目负责人的结果讨论以及培训
项目调查人员在动物程序中(如果需要)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guido Erwin Michael Eibl其他文献
Guido Erwin Michael Eibl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guido Erwin Michael Eibl', 18)}}的其他基金
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
慢性压力和肥胖在胰腺癌进展中的相互作用
- 批准号:
10409304 - 财政年份:2022
- 资助金额:
$ 28.57万 - 项目类别:
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
慢性压力和肥胖在胰腺癌进展中的相互作用
- 批准号:
10612088 - 财政年份:2022
- 资助金额:
$ 28.57万 - 项目类别:
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
肥胖促进的胰腺癌的化学预防和机制
- 批准号:
10398844 - 财政年份:2020
- 资助金额:
$ 28.57万 - 项目类别:
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
肥胖促进的胰腺癌的化学预防和机制
- 批准号:
10605224 - 财政年份:2020
- 资助金额:
$ 28.57万 - 项目类别:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
项目1:肥胖促进的胰腺癌中的脂肪组织炎症
- 批准号:
10398845 - 财政年份:2020
- 资助金额:
$ 28.57万 - 项目类别:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
项目1:肥胖促进的胰腺癌中的脂肪组织炎症
- 批准号:
10605225 - 财政年份:2020
- 资助金额:
$ 28.57万 - 项目类别:
Inflammatory processes In diet-Induced pancreatic cancer promotion
饮食诱发的胰腺癌促进中的炎症过程
- 批准号:
8561427 - 财政年份:2013
- 资助金额:
$ 28.57万 - 项目类别:
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
针对饮食诱导的 Kras 引发的胰腺癌的促进作用
- 批准号:
8337028 - 财政年份:2012
- 资助金额:
$ 28.57万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
- 批准号:
10641225 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Amnion cell secretome mediated therapy for traumatic brain injury
羊膜细胞分泌组介导的创伤性脑损伤治疗
- 批准号:
10746655 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Development of a Micro-coil Based Cochlear Implant
基于微线圈的人工耳蜗的开发
- 批准号:
10658004 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Non-invasive molecular imaging tool for rapid, longitudinal assessment of localized metabolic disruptions in animal research and care
非侵入性分子成像工具,用于快速纵向评估动物研究和护理中的局部代谢紊乱
- 批准号:
10602045 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Diversity Supplement: Advancing novel therapies for optic neuropathy with a nonhuman primate model
多样性补充:利用非人类灵长类动物模型推进视神经病变的新疗法
- 批准号:
10844261 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别: